Pulmonary embolism and COVID-19

Thumbnail Image
Farrell, A. M.
Walsh, L. J.
Plant, Barry J.
Henry, M. T.
Kennedy, Marcus P.
Eustace, Joseph A.
Sadlier, C.
Crowley, M.
Murphy, Desmond M.
Journal Title
Journal ISSN
Volume Title
Irish Medical Organisation
Published Version
Research Projects
Organizational Units
Journal Issue
Aims: There is increasing concern amongst clinicians of a possible increase in venous thromboembolism (VTE) events in patients with COVID-19. There remains limited data defining the incidence of VTE in this population and thus also a paucity of research examining the impact of targeted treatment in patients with thrombotic complications. Methods: We examined the number of symptomatic VTE events amongst proven COVID-19 patients admitted to a tertiary level academic hospital, over a one-month period. Patient characteristics, admission and discharge inflammatory and coagulation markers were included in the analysis. Results: Sixty-one patients were identified. Twelve patients (19.6%) admitted with COVID-19 were treated for a suspected PE. Of these patients, 3 patients were discharged on anticoagulation, 3 died and 6 remain inpatients at the end of the study period. Discussion: COVID-19 patients are at increased risk of VTE. This risk may extend beyond the period of admission. Further research examining the role of extending the duration of thromboprophylaxis in COVID-19 patients beyond hospital discharge is warranted.
COVID-19 , VTE , Venous thromboembolism , Pulmonary embolus , Anticoagulation
Farrell, A. M., Walsh, L. J., Plant, B. J., Henry, M. T., Kennedy, M. P., Eustace, J .E., Sadlier, C., Crowley, M. and Murphy, D. M. (2020) 'Pulmonary embolism and COVID-19', Irish Medical Journal, 113(8), P162 (4pp). Available at: https://imj.ie/wp-content/uploads/2020/09/Pulmonary-Embolism-and-COVID-19.pdf (Accessed: 11 December 2020)
© 2020, Irish Medical Organisation. All rights reserved.